Sign In
Buy MRK
$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
Ashton Thomas Private Wealth LLC Sells 49,784 Shares of Merck & Co., Inc. $MRK
06:38am, Monday, 27'th Apr 2026
Ashton Thomas Private Wealth LLC trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 29.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities a
FARMERS & MERCHANTS TRUST Co OF LONG BEACH Sells 4,880 Shares of Merck & Co., Inc. $MRK
06:00am, Monday, 27'th Apr 2026
FARMERS and MERCHANTS TRUST Co OF LONG BEACH lowered its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 37.5% during the undefined quarter, according to the company in its most recent filing wi
Comerica Bank Reduces Position in Merck & Co., Inc. $MRK
05:10am, Monday, 27'th Apr 2026
Comerica Bank lessened its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 93
Anchyra Partners LLC Purchases New Position in Merck & Co., Inc. $MRK
03:57am, Monday, 27'th Apr 2026
Anchyra Partners LLC acquired a new position in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The in
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
01:57am, Monday, 27'th Apr 2026
Organon and Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's g
Brindle & Bay Financial Advisors LLC Invests $778,000 in Merck & Co., Inc. $MRK
04:06am, Sunday, 26'th Apr 2026
Brindle and Bay Financial Advisors LLC purchased a new position in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purch
Merck & Co., Inc. $MRK Stake Increased by AEGON ASSET MANAGEMENT UK Plc
03:15am, Sunday, 26'th Apr 2026
AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 3.0% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund ow
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
06:46pm, Friday, 24'th Apr 2026
In the latest trading session, Merck (MRK) closed at $111.9, marking a -2.37% move from the previous day.
Will Lower Gardasil Sales Hurt MRK's Vaccines Sales in Q1 Earnings?
10:11am, Friday, 24'th Apr 2026
Gardasil's sharp sales slump in China and Japan puts Merck under pressure heading into Q1 earnings, as new vaccine Capvaxive gains momentum.
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
06:45am, Friday, 24'th Apr 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act o
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
11:05am, Thursday, 23'rd Apr 2026
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study
01:15pm, Wednesday, 22'nd Apr 2026
Merck stock slides as Keytruda-based triplet therapy misses main goals in a late-stage study in first-line advanced renal cell carcinoma.
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
08:00am, Wednesday, 22'nd Apr 2026
New collaboration taps Gemini Enterprise to realize business-driving value, innovation and patient impact across the next era of biopharmaceutical growth LAS VEGAS, April 22, 2026 /PRNewswire/ -- Clou
Merck to partner with Google Cloud on AI initiatives
07:02am, Wednesday, 22'nd Apr 2026
Drugmaker Merck & Co said on Wednesday it will partner with Google Cloud to build up its artificial intelligence capabilities, investing as much as $1 billion with Google over a number of years to
Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say
07:02am, Wednesday, 22'nd Apr 2026
Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co , Germany's Merck KGaA and Japan's Ono Pharmaceutical for an experimental cancer treatment that could be valued at more t
